ALB and neuroblastoma: In the neuroblastoma cell line UKF-NB-3, the nanoparticle preparations displayed similar activity as doxorubicin solution, with doxorubicin-loaded HSA (40%), HSA (100%), and HSA (200%) nanoparticles potentially showing a trend towards a slightly increased activity (Figure 3).